Journal articles
- Research
- Our research
- For patients and consumers
- Clinical Trials
- Pre-approval planning
- Ethics approval
- Research governance
- Post-approval submissions
- Supporting research
- Contact Us
Metro North is committed to providing a platform to acknowledge and promote research excellence within our health service. Below is a list of research publications from across our hospitals and services.
- A novel case of presumed immunotherapy related inflammatory orbitopathy 23 December 2025Chimeric antigen receptor T-cell (CAR T) therapy is an innovative form of cancer treatment, wherein a patient's own T cells are genetically modified to incorporate chimeric antigen receptors (CARs), enabling them to selectively identify and destroy cancer cells. This personalised T cell-based immunotherapy has shown promising results in treating hematological malignancies, such as certain types […]Liam C Kalas
- Successful Management of an Abdominal Fistularising Lymphoma Without Surgery 23 December 2025No abstractPooja Nagaratnam
- Pulmonary Complications After Cardiac Surgical Procedures: A Tertiary Centre Audit of Elective and Urgent Cases 22 December 2025CONCLUSIONS: Pulmonary complications increased after urgent compared with elective cardiac surgical procedures, with a higher incidence of pneumonia, respiratory failure, pleural effusion, and pulmonary embolism.Usha Gurunathan
- Criteria pharmacists use to refer patients to a post discharge pharmacist review clinic 22 December 2025CONCLUSION: Pharmacists used established criteria from clinical resources to identify high-risk patients for referral; however, they also relied on clinical judgement. Referrals aimed to prevent medication related harm and improve communication with patients and healthcare providers. Future research should evaluate the effectiveness of clinical judgement to ensure high-risk patients are identified for transition of care […]Adrienne Kostellar
- Data analysis of the Queensland Difficult Airway Alert Project 22 December 2025No abstractJane Elms
- A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation 22 December 2025CONCLUSION: In patients undergoing MCS device implantation, intravenous fluconazole 200 mg administered pre-operatively and continued daily for 5 days is insufficient for Candida spp. with MICs > 1 mg/L (prophylaxis, AUC(0-24)/MIC ≥ 50) and > 0.5 mg/L (treatment, AUC(0-24)/MIC ≥ 100).Kelly A Cairns
- High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD) 21 December 2025CONCLUSION: Vitamin D supplementation did not prevent PC progression, although reduced prevalence of CBMN markers may indicate a benefit of vitamin D supplementation.Visalini Nair-Shalliker
- Intestinal Ultrasound for Inflammatory Bowel Disease: The Sound at the End of the Tunnel? 20 December 2025No abstractR Gilmore
- Current Antibiotic Options for the Treatment of Infections with AmpC-Producing Enterobacterales 20 December 2025AmpC β-lactamases, found in certain Enterobacterales, confer resistance to third-generation cephalosporins, some β-lactam/β-lactamase inhibitor combinations, and cephamycins. They may be chromosomal or plasmid-mediated. Generally, third-generation cephalosporins are avoided in the treatment of high-risk AmpC producers, with cefepime or carbapenems being preferred for severe infections. Non-β-lactam options (fluoroquinolones, trimethoprim-sulfamethoxazole, and aminoglycosides) remain viable...Jinghao Nicholas Ngiam
- Rapid Diagnostic Strategies for Antibiotic-Resistant Bacteria Causing Bloodstream Infection 20 December 2025Novel technologies for the diagnosis of bloodstream infection are emerging, with the potential to improve patient care. Antimicrobial stewardship programs have proven essential to embed such tests into clinical practice and thus support early appropriate antimicrobial therapy. Yet, the best implementation strategies for these tests are still unknown and likely dependent on the specific scenarios, […]Anna Maria Peri
- Pelvic lymph node dissection in prostate cancer, still no level 1 evidence of oncological benefit. Time to consider surveillance of negative pelvic lymph nodes on PSMA PET scan staging 20 December 2025No abstractJ W Yaxley
- Corrigendum to "Long-term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials" [American Heart Journal (278)2024 Page Number:106-116] 19 December 2025No abstractSheldon E Litwin
- Mobilisation OverViEw in a Quaternary intensive care unit: A cross-sectional descriptive survey 19 December 2025CONCLUSIONS: This study highlights low awareness of EM guidelines and the presence of persistent system-level barriers to EM despite clinicians' positive attitudes and intentions. Findings suggest that stronger guideline dissemination, education, and practical supports are needed to embed EM into routine ICU practice. Future research should focus on implementation strategies and evaluation of safe, context-specific […]Andrew J Neilson
- Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group 19 December 2025We describe the rationale for using quantification of Gleason pattern 4 rather than the proportion of Gleason patterns for risk stratification in prostate cancer, as proposed by the ProQuant Group. We outline research that will be conducted to assess this strategy, and invite individuals interested in collaboration to join the group.Andrew J Vickers
- Humidity-driven ABA depletion determines plant-pathogen competition for leaf water 19 December 2025Bacterial phytopathogens, such as Pseudomonas syringae pv. tomato (Pst) DC3000, induce water-soaked lesions in the leaf apoplast under high humidity, facilitating infection. However, it remains largely unclear how plants regulate their resistance to restrict bacterial infection in response to humidity. Here, we demonstrate that abscisic acid (ABA)-catabolizing ABA 8'-hydroxylase, encoded by CYP707A3, plays a critical […]Shigetaka Yasuda
